Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Britannia Life Sciences Inc (TSE:BLAB)
CNQX:BLAB
Holding TSE:BLAB?
Track your performance easily
BLAB Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.03 - C$0.11
Previous CloseC$0.08
Volume0.00
Average Volume (3M)28.13K
Market Cap
C$12.23M
Enterprise ValueC$22.70M
Total Cash (Recent Filing)C$742.36K
Total Debt (Recent Filing)C$6.89M
Price to Earnings (P/E)―
Beta-0.68
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding162,254,339
10 Day Avg. Volume9,524
30 Day Avg. Volume28,128
Standard Deviation1.43
R-Squared0.00433
Alpha0.24
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)8.00
Price to Sales (P/S)1.76
Price to Cash Flow (P/CF)249.00
P/FCF Ratio16.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Britannia Life Sciences Inc News
PremiumCompany Announcements
Britannia Life Sciences Reports Successful Shareholder Meeting
PremiumCompany Announcements
Britannia Life Sciences Launches Strategic Financing DrivePremiumCompany Announcements
Britannia Life Sciences Back on Track with OSC
PremiumCompany Announcements
Britannia Life Sciences Announces Growth and Expansion
PremiumCompany Announcements
Britannia Life Sciences Addresses Cease Trade Concerns
PremiumCompany Announcements
Britannia Life Sciences Inc. Faces Cease Trade Amid Audit Delay
PremiumCompany Announcements
Britannia Secures Funds Through Private PlacementPremiumCompany Announcements
Britannia Life Sciences Plans Capital BoostOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
― Other Institutional Investors
99.02% Public Companies and
Individual Investors
BLAB FAQ
What was Britannia Life Sciences Inc’s price range in the past 12 months?
Britannia Life Sciences Inc lowest stock price was C$0.03 and its highest was C$0.11 in the past 12 months.
What is Britannia Life Sciences Inc’s market cap?
Currently, no data Available
When is Britannia Life Sciences Inc’s upcoming earnings report date?
Britannia Life Sciences Inc’s upcoming earnings report date is Feb 26, 2025 which is in 64 days.
How were Britannia Life Sciences Inc’s earnings last quarter?
Britannia Life Sciences Inc released its earnings results on Nov 29, 2024. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
Is Britannia Life Sciences Inc overvalued?
According to Wall Street analysts Britannia Life Sciences Inc’s price is currently Overvalued.
Does Britannia Life Sciences Inc pay dividends?
Britannia Life Sciences Inc does not currently pay dividends.
What is Britannia Life Sciences Inc’s EPS estimate?
Britannia Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Britannia Life Sciences Inc have?
Britannia Life Sciences Inc has 152,887,530 shares outstanding.
What happened to Britannia Life Sciences Inc’s price movement after its last earnings report?
Britannia Life Sciences Inc reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Britannia Life Sciences Inc?
Currently, no hedge funds are holding shares in TSE:BLAB
---
Britannia Life Sciences Inc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.28%
12-Months-Change
Fundamentals
Return on Equity
-155.17%
Trailing 12-Months
Asset Growth
-4.67%
Trailing 12-Months
Company Description
Britannia Life Sciences Inc
RISE Life Science Corp is engaged in developing and evolving medical and adult hemp-based formulations to create general use of health and well-being products for the emerging consumer category.
---
Technical Analysis
---